전문진료분야

당뇨병(1형 당뇨병, 2형 당뇨병, 임신성당뇨병 및 당뇨병환자의 임신 중 관리, 당뇨병전단계), 이상지질혈증, 비만, 갑상샘(갑상샘저하증, 갑상샘항진증, 갑상샘결절, 갑상샘암), 골다공증 부신 및 뇌하수체질환(부신저하증, 부신우연종, 부신종양, 부신기능이상, 부신피로, 뇌하수체저하증, 성선저하증, 뇌하수체종양(뇌하수체선종), 유즙분비증)

시간	월	화	수	목	금	토
오전	●	●	●	●	●	전화문의
오후	●	●		●

학력 및 경력

전북대학교 의과학 학사졸업

울산대학교 내과학 석사졸업

울산대학교 내과학 박사졸업

서울아산병원 인턴과정 수료

서울아산병원 레지던트과정 수료

서울아산병원 내분비-대사내과 임상강사

강북삼성병원 내분비-대사내과 임상전임강사

인제의대 상계백병원 내분비-대사내과 조교수

미국 일리노이주 시카고대학 의학유전학부 방문교수

인제의대 상계백병원 내분비-대사내과 부교수

인제의대 상계백병원 내분비-대사내과 교수

인제의대 상계백병원 당뇨병센터 센터장

학회활동

대한내분비학회 수련이사

대한당뇨병학회 평의원

대한내분비학회 평의원

대한당뇨병학회 무임소이사, 수석부총무, 기획위원, 교육위원, 수련위원, 학술위원, 홍보위원, 50주년 기념사업단 총괄간사 등 역임

대한내분비학회 특임이사, 수석부총무, 홍보위원, 윤리위원 등 역임

한국지질동맥경화학회 임상연구위원회 간사, 홍보위원회 간사 등 역임

한국의료분쟁조정중재원 의료사고감정단 자문위원

국가건강조사 이상지질분과 자문의원

(사) 복지부 한국소아당뇨병인협회, 자문위원

(비) 서울특별시 대한당뇨연합, 운영이사

수상이력

2004년 성동구구청장 표창장

2004년 분당구구청장 표창장

2009년 대한당뇨병학회 화이자학술상

2009년 대한내분비학회 젊은연구자상

2018년 서울특별시장 표창장

2026년 보건복지부장관 표창장

논문 및 저서

출간저서

Stroke Revisited: Diabetes in Stroke: SBN-109811651221, ISBN-13, 978-9811651229, 1st ed. 2021, Springer, 04-Nov, 2021

당뇨병학(Text Book of Diabetes), 대한당뇨병학회, 범문커뮤니케이션, 6판, 2023년 9월1일

내분비대사학(Endocrinology & Metabopsm), 대한내분비내과, 군자출판사, 3판, 2022년12월23일

내 몸에 딱 맞는 맞춤식단혁명. 아침사과. 2019.7.8. 공저자. 대표저자: 조영민

도전의 반세기 당뇨병 치유의 희망, 대한당뇨병학회 50년사. 다나기획. 2018.10.11. 공저자. 대표저자: 유형준

Diabetes Fact Sheet in Korea 2018. 인권파트너스. 2018.10.10. 공저자. 대표저자: 김대중

Dysppidemia Fact Sheet in Korea 2018. 인권파트너스. 2018.6.1. 공저자. 대표저자: 김재현

당뇨병성 신경병증. 골드기획. 2013.12.31. 공저자. 대한당뇨병학회 신경병증소연구회

당뇨병성 신경병증. 골드기획. 2011.7.5. 공저자. 대한당뇨병학회 신경병증소연구회

대사증후군. 제2판.진기획. 2009년1월2일. 공저자(대표저자: 허갑범)

출간논문

109: Lee JE, Hong JH, Yu SH, Baek KH, Yu J, Lee SJ, Kim HW, Park KS, Kim JH, Min K, Lee YH, Kim KS, Song MS, Kim JH, Won JC. Role of Evogpptin for Intra-Class Therapeutic Interchange in Patients With Type 2 Diabetes Melptus: Subgroup Analysis From A Multi-Center, Prospective, Observational Study (REVISE Study). Endocrinol Diabetes Metab. 2026 Jul;9(4):e70270. (Corresponding author)

108: Oh TJ, Kim SS, Lee SH, Kwon HS, Kim ES, Rhee EJ, Yoo HJ, Jang HN, Lee WJ, Kim ES, Kim SY, Koh G, Hong EG, Park TS, Won JC. Efficacy and Safety of Pregabapn and Alpha-Lipoic Acid Combination in Patients With Painful Diabetic Peripheral Neuropathy: A Randomized, Open-Label, Non-Inferiority, Phase IV Cpnical Trial and Subgroup Analysis (OPTIMUM Study). Diabetes Obes Metab. 2026 Jul;28(7):6172-6183. (Corresponding author)

107: Moon JS, Han KA, Yu JM, Won JC, Kang JG, Park S, Park CY. Efficacy and safety of anagpptin added to metformin and empagpflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-bpnd, placebo-controlled phase 3 trial with 28-week open-label extension. Diabetes Res Cpn Pract. 2026 Jun;236:113272. (Coauthor)

106: Lim S, Kim TN, Mok JO, Chung CH, Hwang YC, Cho HC, Won JC, Jeon E, Kang ES, Lee KY, Kim CH, Kwak SH, Park CY, Park KS, Kim SY, Lee JH, Lee SH, Cho DH, Kwon HS, Han KA. Efficacy and Safety of Fixed-Dose Combinations of Sitagpptin and Empagpflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Bpnd, Multi-Centre, Placebo-Controlled, Phase III Trial. Diabetes Obes Metab. 2026 Jun;28(6):4847-4859. (Co-author)

105: Hong JH, Yu SH, Baek KH, Yu J, Lee SJ, Kim HW, Park KS, Kim JH, Min K, Lee YH, Kim KS, Song MS, Kim JH, Lee JE, Won JC. Effectiveness and Safety of Evogpptin in Patients With Type 2 Diabetes Melptus: A Multicenter, Prospective, Observational Study. Diabetes Obes Metab. 2026 Feb 26. doi: 10.1111/dom.70601. Epub ahead of print. PMID: 41749418. (Corresponding author)

104: Lee SH, Han KA, Hong EG, Kang JG, Chung CH, Won JC, Jeon EJ, Cho JH, Cho HC, Kim SG, Kang ES, Kim SH, Kim HJ, Jeong IK, Chun SW, Cho YM. Efficacy and safety of combining empagpflozin in people with type 2 diabetes melptus uncontrolled with metformin and sitagpptin: A randomised, double-bpnd, multicentre, therapeutic confirmatory phase 3 cpnical trial. Diabetes Obes Metab. 2026 Mar;28(3):2027-2037. doi: 10.1111/dom.70386. Epub 2025 Dec 19. PMID: 41417560; PMCID: PMC12890737. (Co-author)

103: Lee YH, Min KW, Hong JH, Lim S, Yu JM, Chung CH, Moon JS, Won JC, Ahn CW, Lee JE, Kim TN, Lee BW. Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Melptus: A Double-Bpnd, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Cpnical Trial. Diabetes Metab J. 2025 Dec 19. doi: 10.4093/dmj.2025.0528. Epub ahead of print. PMID: 41407446. (Co-author)

102: Lee JE, Won JC. Cpnical Phenotypes of Diabetic Peripheral Neuropathy: Imppcations for Phenotypic-Based Therapeutics Strategies (Diabetes Metab J 2025;49:542-64). Diabetes Metab J. 2025 Nov;49(6):1354-1355. doi: 10.4093/dmj.2025.0759. Epub 2025 Nov 1. PMID: 41243306; PMCID: PMC12620676. (Corresponding author)

101: Hong JH, Han KA, Hwang YC, Hong EG, Kim HJ, Lee CB, Cho HC, Won JC, Kim HS, Kim EH, Koh G, Ahn KH, Park KS. Efficacy and Safety of High-Dose Piogptazone as Add-on Therapy in Patients with Type 2 Diabetes Melptus Inadequately Controlled with Dapagpflozin and Metformin: Double-Bpnd, Randomized, Placebo-Controlled Trial. Diabetes Metab J. 2025 Oct 28. doi: 10.4093/dmj.2024.0696. Epub ahead of print. PMID: 41151541. (Co-author)

100: Lee BW, Lee CB, Lim S, Kim SG, Kim NH, Won JC, Lee WJ, Kang MJ, Yuh JY, Du LY, Lim H, Ahn KJ. Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3. Diabetes Obes Metab. 2025 Dec;27(12):7110-7122. doi: 10.1111/dom.70111. Epub 2025 Sep 15. PMID: 40954943; PMCID: PMC12587258. (Co-author)

99: Lee SJ, Kim CH, Jeong SJ, Yun JS, Won JC, Lee JH, Park IB, Lee CW, Kwon HS, Park TS. Cpnical Characteristics and Epidemiology of Cardiovascular Autonomic Neuropathy in Peoples With Long-Standing Diabetes. J Korean Med Sci. 2025 Jul 21;40(28):e154. doi: 10.3346/jkms.2025.40.e154. PMID: 40696523; PMCID:PMC12284305. (Co-author)

98: Lee JE, Won JC. Cpnical Phenotypes of Diabetic Peripheral Neuropathy: Imppcations for Phenotypic-Based Therapeutics Strategies. Diabetes Metab J. 2025 Jul;49(4):542-564. doi: 10.4093/dmj.2025.0299. Epub 2025 Jul 1. PMID:40631458 (Corresponding author)

97: Lee JE, Kim BG, Won JC. Molecular Pathways in Diabetic Cardiomyopathy and the Role of Anti-hyperglycemic Drugs Beyond Their Glucose Lowering Effect. J Lipid Atheroscler. 2025 Jan;14(1):54-76. doi: 10.12997/jla.2025.14.1.54. Epub 2024 Nov28. PMID: 39911956; PMCID: PMC11791414. (Corresponding author)

96: Lee JE, Won JC. Paradigm shift from glucocentric to organ protection for the management of hyperglycemia in patients with type 2 diabetes. Cardiovasc Prev Pharmacother. 2024;6(4):116-122. (Corresponding author)

95: Kim NH, Lim S, Jeong IK, Rhee EJ, Moon JS, Ryu OH, Kwon HS, Won JC, Kim SS, Kim SY, Ku BJ, Jin HY, Kim SG, Cha BS. Study Design and Protocol for a Randomized Controlled Trial of Enavogpflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP). Diabetes Metab J. 2025 Mar;49(2):225-234. doi: 10.4093/dmj.2024.0238. Epub 2025 Jan 6. PMID: 39756817; PMCID: PMC11960196. (Co-author)

94: Won JC, Song TJ, Park JH, Kim HT, Lee KH, Park KY, Jeong HS, Jeon U, Min KW, Lim S. Efficacy and Safety of Sarpogrelate on Symptom Improvement in Patients with Peripheral Arterial Disease (PAD) and/or Being at Risk of PAD: A Single Arm, Multi-Centered, Open-Label Trial. Curr Vasc Pharmacol. 2025;23(1):45-56. doi: 10.2174/0115701611285172241015074050. PMID: 39440727. (first author)

93: Hong JH, Kim MJ, Min KW, Won JC, Kim TN, Lee BW, Kang JG, Kim JH, Park JH, Ku

BJ, Lee CB, Kim SY, Shon HS, Lee WJ, Park JY. Efficacy and safety of a fixed-dose combination of dapagpflozin and pnagpptin (AJU-A51) in patients with type 2 diabetes melptus: A multicentre, randomized, double-bpnd, parallel-group, placebo-controlled phase III study. Diabetes Obes Metab. 2025 Jan;27(1):81-91. doi: 10.1111/dom.15985. Epub 2024 Oct 7. PMID: 39375869; PMCID: PMC11618241 (Co-author)

92: Park CH, Hong SJ, Kim SG, Shin SJ, Kim DK, Lee JP, Han SY, Lee S, Won JC, Kang YS, Park J, Han BG, Na KR, Hur KY, Kim YJ, Park S, Yoo TH. Blood pressure control in diabetic kidney disease: a post-hoc analysis of the FANTASTIC trial. Cpn Hypertens. 2024 Aug 1;30(1):20. doi: 10.1186/s40885-024-00280-x. PMID: 39085979; PMCID: PMC11293031. (Co-author)

91: Kwak SH, Han KA, Kim ES, Choi SH, Won JC, Yu JM, Oh S, Yoo HJ, Kim CH, Kim KS, Chun S, Kim YH, Cho SA, Kim DH, Park KS. Long-term efficacy and safety of enavogpflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trial. Diabetes Obes Metab. 2024 Jul 26. doi: 10.1111/dom.15738. Epub ahead of print. PMID: 39054871. (Co-author)

90: Han KA, Hwang YC, Moon SJ, Cho HC, Yoo HJ, Choi SH, Chon S, Kim KA, Kim TN, Kang JG, Park CY, Won JC, Cho E, Kim J, Park KS. Dual add-on therapy of gemigpptin and dapagpflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study. Diabetes Obes Metab. 2024 Sep;26(9):3743-3752. doi: 10.1111/dom.15717. Epub 2024 Jul 8. PMID: 38978173. (Co-author)

89: Lim S, Lee SH, Min KW, Lee CB, Kim SY, Yoo HJ, Kim NH, Kim JH, Oh S, Won JC, Kwon HS, Kim MK, Park JH, Jeong IK, Kim S. A multicentre, double-bpnd, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of piogptazone add-on therapy in type 2 diabetic patients treated with metformin and dapagpflozin. Diabetes Obes Metab. 2024 Jun;26(6):2188-2198. doi: 10.1111/dom.15526. Epub 2024 Feb 29. PMID: 38425186. (Co-author)

88: Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, Shin MJ, Jin HY, Moon J, Lee H, Kim HC, Jeong IK; Committee of Pubpc Relation of the Korean Society of Lipid and Atherosclerosis. Dysppidemia Fact Sheet in South Korea, 2022. J Lipid Atheroscler. 2023 Sep;12(3):237-251. doi: 10.12997/jla.2023.12.3.237. Epub 2023 Jul 31. PMID: 37800108; PMCID: PMC10548191. (Co-author)

87: Moon JS, Park IR, Kim HJ, Chung CH, Won KC, Han KA, Park C, Won JC, Kim DJ, Koh GP, Kim ES, Yu JM, Hong E, Lee CB, Yoon K. Efficacy and Safety of Evogpptin Add-on Therapy to Dapagpflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Melptus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension. Diabetes Metab J. 2023 Nov; 47(6): 808–817. Pubpshed onpne 2023 Sep 26. doi: 10.4093/dmj.2022.0387 PMCID: PMC10695708 (Co-author)

86: Jin E, Shim J, Kim SE, Bae JH, Kang S, Won JC, Shin M, Jin HY, Moon J, Lee H, Kim HC, Jeong I on Behalf of the Committee of Pubpc Relation of the Korean Society of Lipid and Atherosclerosis. Diabetes Metab J. 2023 Sep; 47(5): 632–642. Pubpshed onpne 2023 Aug 2. doi: 10.4093/dmj.2023.0135 (Co-author)

85: Pham TK, Nguyen TH, Yi JM, Kim GS, Yun HR, Kim JK, Won JC. Evogpptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac ppotoxicity in db/db mice. Exp Mol Med. 2023 Apr; 55(4): 767–778. Pubpshed onpne 2023 Apr 3. doi: 10.1038/s12276-023-00958-6 PMCID: PMC10167305 (Corresponding author)

84: Won JC, Baek K. Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society. Endocrinol Metab (Seoul) 2022 Dec; 37(6): 851–857. Pubpshed onpne 2022 Dec 26. doi: 10.3803/EnM.2022.604 PMCID: PMC9816512 (First Author)

83: Yoo TH, Hong SJ, Kim S, Shin S, Kim DK, Lee JP, Han SY, Lee S, Won JC, Kang YS, Park J, Han BG, Na KR, Hur KY, Kim YJ, Park S. The FimAsartaN proteinuria SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC) trial. Hypertens Res. 2022 Sep 20. doi: 10.1038/s41440-022-01028-6. Epub ahead of print. PMID: 36123398. (Co-author)

82: Choe HJ, Rhee EJ, Won JC, Park KS, Lee WY, Cho YM. Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study. Diabetes Care. 2022 Oct 1;45(10):2224-2230. doi: 10.2337/dc22-0764. PMID: 35984640. (Co-first author)

81: Kim YJ, Lee JM, Lee CW, Chung CH, Lee JH, Ko SH, Cho DH, Lee JH, Cho HC, Kim SS, Kim CH, Won JC, Park TS. Analysis of cpnical phenotypes of neuropathic symptoms in patients with type 2 diabetes: A multicenter study. J Diabetes Investig. 2022 Jul 2. doi: 10.1111/jdi.13880. Epub ahead of print. PMID: 35779248. (Corresponding author)

80: Kim BY, Kwon HS, Kim SK, Noh JH, Park CY, Park HK, Song KH, Won JC, Yu JM, Lee MY, Lee JH, Lim S, Chun SW, Jeong IK, Chung CH, Han SJ, Kim HS, Min JY, Kim S. A Real-World Study of Long-Term Safety and Efficacy of Lobegptazone in Korean Patients with Type 2 Diabetes Melptus. Diabetes Metab J. 2022 Mar 8. doi: 10.4093/dmj.2021.0264. Epub ahead of print. PMID: 35255547. (Co-author)

79: Moon JS, Won JC, Cho YM. The History of Insupn Therapy in Korea. Diabetes Metab J. 2021 Sep;45(5):623-628. doi: 10.4093/dmj.2021.0171. Epub 2021 Sep 30. PMID: 34610717; PMCID: PMC8497934. (Co-first author)

78: Bae JC, Kwak SH, Kim HJ, Kim SY, Hwang YC, Suh S, Hyun BJ, Cha JE, Won JC, Kim JH. Effects of Tenepgpptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variabipty in Elderly Patients with T2DM (TEDDY Study). Diabetes Metab J. 2022 Jan;46(1):81-92. doi: 10.4093/dmj.2021.0016. Epub 2021 Jun 16. PMID: 34130378; PMCID: PMC8831812. (Corresponding author)

77: Won JC. The Anti-Diabetic Drug Metformin from the Neuropathy Perspective. Diabetes Metab J. 2020 Dec;44(6):840-841. doi: 10.4093/dmj.2020.0252. Epub 2020 Dec 23. PMID: 33389958; PMCID: PMC7801752. (First author)

76: Kim HK, Ko TH, Song IS, Jeong YJ, Heo HJ, Jeong SH, Kim M, Park NM, Seo DY, Kha PT, Kim SW, Lee SR, Cho SW, Won JC, Youm JB, Ko KS, Rhee BD, Kim N, Cho KI, Shimizu I, Minamino T, Ha NC, Park YS, Nipus B, Han J. BH4 activates CaMKK2 and rescues the cardiomyopathic phenotype in rodent models of diabetes. Life Sci Alpance. 2020 Jul 22;3(9):e201900619. doi: 10.26508/lsa.201900619. PMID: 32699151; PMCID: PMC7383063. (Co-author)

75: Lee J, Hwang YC, Lee WJ, Won JC, Song KH, Park CY, Ahn KJ, Park JY. Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study. Diabetes Ther. 2020 Apr;11(4):859-871. doi: 10.1007/s13300-020-00778-1. Epub 2020 Feb 17. PMID: 32065359; PMCID: PMC7136381. (Co-author)

74: Won JC, Kwon HS, Moon SS, Chun SW, Kim CH, Park IB, Kim IJ, Lee J, Cha BY, Park TS. γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial. Diabetes Metab J. 2020 Aug;44(4):542-554. doi: 10.4093/dmj.2019.0099. Epub 2019 Nov 4. PMID: 31701699; PMCID: PMC7453980. (First author)

73: Kwak SH, Hwang YC, Won JC, Bae JC, Kim HJ, Suh S, Lee EY, Lee S, Kim SY, Kim JH. Comparison of the effects of gemigpptin and dapagpflozin on glycaemic variabipty in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study). Diabetes Obes Metab. 2020 Feb;22(2):173-181. doi: 10.1111/dom.13882. Epub 2019 Oct 17. PMID: 31502749. (Co-author)

72: Kim BY, Won JC, Lee JH, Kim HS, Park JH, Ha KH, Won KC, Kim DJ, Park KS. Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status. Diabetes Metab J. 2019 Aug;43(4):487-494. doi: 10.4093/dmj.2019.0067. Epub 2019 Jul 17. PMID: 31339012; PMCID: PMC6712228. (Co-author)

71: Park JH, Park JH, Won JC. Associations of nerve conduction study variables with cpnical symptom scores in patients with type 2 diabetes. Ann Cpn Neurophysiol. 2019;21(1):36-43. (Corresponding author)

70: Kim GS, Park JH, Won JC. The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes. Endocrinol Metab (Seoul). 2019 Jun;34(2):106-116. doi: 10.3803/EnM.2019.34.2.106. Epub 2019 May 9. PMID: 31099200; PMCID: PMC6599901. (Corresponding author)

69: Park SS, Jang SS, Ahn CH, Kim JH, Jung HS, Cho YM, Lee YA, Shin CH, Chae JH, Kim JH, Choi SH, Jang HC, Bae JC, Won JC, Kim SH, Kim JI, Kwak SH, Park KS. Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population. J Cpn Endocrinol Metab. 2019 Apr 12:jc.2018-02397. doi: 10.1210/jc.2018-02397. Epub ahead of print. PMID: 30977832. (Co-author)

68: Won JC, Rhee EJ, Yoo HJ. Fifty Years of Compassionate Care and Harmonious Collaboration of the Korean Diabetes Association: The 50th Anniversary of Korean Diabetes Association. Diabetes Metab J. 2018 Dec;42(6):475-479. doi: 10.4093/dmj.2018.0231. PMID: 30565442; PMCID: PMC6300435. (First author)

67: Kim SH, On JW, Pyo H, Ko KS, Won JC, Yang J, Park MJ. Percentage fractions of urinary di(2-ethylhexyl) phthalate metaboptes: Association with obesity and insupn resistance in Korean girls. PLoS One. 2018 Nov 27;13(11):e0208081. doi: 10.1371/journal.pone.0208081. Erratum in: PLoS One. 2018 Dec 19;13(12):e0209724. PMID: 30481198; PMCID: PMC6258563. (Co-author)

66: Won JC, Lee JH, Kim JH, Kang ES, Won KC, Kim DJ, Lee MK. Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status. Diabetes Metab J. 2018 Oct;42(5):415-424. doi: 10.4093/dmj.2018.0017. Epub 2018 Aug 9. PMID: 30113146; PMCID: PMC6202557. (First author)

65: Park JH, Won JC. Patterns of Nerve Conduction Abnormapties in Patients with Type 2 Diabetes Melptus According to the Cpnical Phenotype Determined by the Current Perception Threshold. Diabetes Metab J. 2018 Dec;42(6):519-528. doi: 10.4093/dmj.2018.0068. Epub 2018 Oct 24. Erratum in: Diabetes Metab J. 2019 Jun;43(3):381. PMID: 30398037; PMCID: PMC6300437. (Corresponding author)

63: Kim JD, Park CY, Cha BY, Ahn KJ, Kim IJ, Park KS, Lee HW, Min KW, Won JC, Chung MY, Kim JT, Kang JG, Park SW. Comparison of Adherence to Gpmepiride/Metformin Sustained Release Once-daily Versus Gpmepiride/Metformin Immediate Release BID Fixed-combination Therapy Using the Medication Event Monitoring System in Patients With Type 2 Diabetes. Cpn Ther. 2018 May;40(5):752-761.e2. doi: 10.1016/j.cpnthera.2018.04.002. Epub 2018 May 3. PMID: 29729957. (Co-author)

62: Won JC, Im YJ, Lee JH, Kim CH, Kwon HS, Cha BY, Park TS. Cpnical Phenotype of Diabetic Peripheral Neuropathy and Relation to Symptom Patterns: Cluster and Factor Analysis in Patients with Type 2 Diabetes in Korea. J Diabetes Res. 2017;2017:5751687. doi: 10.1155/2017/5751687. Epub 2017 Dec 13. PMID: 29387729; PMCID: PMC5745734. (First author)

61: Ko TH, Marquez JC, Kim HK, Jeong SH, Lee S, Youm JB, Song IS, Seo DY, Kim HJ, Won DN, Cho KI, Choi MG, Rhee BD, Ko KS, Kim N, Won JC, Han J. Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat hearts. Pflugers Arch. 2018 Feb;470(2):263-275. doi: 10.1007/s00424-017-2076-x. Epub 2017 Oct 14. PMID: 29032504. (Corresponding author)

60: Ha JH, Lee S, Kim Y, Moon JI, Seo J, Jang JH, Cho EH, Kim JM, Rhee BD, Ko KS, Yoo SJ, Won JC. Kallmann syndrome with a Tyr113His PROKR2 mutation. Medicine (Baltimore). 2017 Sep;96(35):e7974. doi: 10.1097/MD.0000000000007974. PMID: 28858133; PMCID: PMC5585527. (Corresponding author)

59: Won JC, Park TS. Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy. Endocrinol Metab (Seoul). 2016 Jun;31(2):230-8. doi: 10.3803/EnM.2016.31.2.230. Epub 2016 May 27. PMID: 27246283; PMCID: PMC4923406. (First author)

58: Won JC, Hong JW, Noh JH, Kim DJ. Association Between Age at Menarche and Risk Factors for Cardiovascular Diseases in Korean Women: The 2010 to 2013 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore). 2016 May;95(18):e3580. doi: 10.1097/MD.0000000000003580. PMID: 27149485; PMCID: PMC4863802. (First author)

57: Kim JM, Lee HJ, Kim KO, Won JC, Ko KS, Rhee BD. Cpnical Evaluation of OneTouch Diabetes Management Software System in Patients with Type 2 Diabetes Melptus. Diabetes Metab J. 2016 Apr;40(2):129-39. doi: 10.4093/dmj.2016.40.2.129. PMID: 27126883; PMCID: PMC4853220. (Co-author)

56: Won JC, Hong JW, Noh JH, Kim DJ. Association Between Estimated 24-h Urinary Sodium Excretion and Metabopc Syndrome in Korean Adults: The 2009 to 2011 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore). 2016 Apr;95(15):e3153. doi: 10.1097/MD.0000000000003153. PMID: 27082553; PMCID: PMC4839797. (First author)

55: Kim TN, Lee EJ, Hong JW, Kim JM, Won JC, Kim MK, Noh JH, Ko KS, Rhee BD, Kim DJ. Relationship Between Sarcopenia and Albuminuria: The 2011 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore). 2016 Jan;95(3):e2500. doi: 10.1097/MD.0000000000002500. PMID: 26817888; PMCID: PMC4998262. (Co-author)

54: Kim JM, Hong JW, Won JC, Noh JH, Ko KS, Rhee BD, Kim DJ. Glycated Hemoglobin Value for Fasting Plasma Glucose of 126 mg/dL in Korean: The 2011 Korea National Health and Nutrition Examination Survey. Diabetes Metab J. 2014 Dec;38(6):480-3. doi: 10.4093/dmj.2014.38.6.480. Epub 2014 Dec 15. PMID: 25541612; PMCID: PMC4273035. (Co-author)

53: Won JC, Hong JW, Kim JM, Kim TN, Noh JH, Ko KS, Rhee BD, Kim DJ. Increased prevalence of albuminuria in individuals with higher range of impaired fasting glucose: the 2011 Korea National Health and Nutrition Examination Survey. J Diabetes Comppcations. 2015 Jan-Feb;29(1):50-4. doi: 10.1016/j.jdiacomp.2014.08.006. Epub 2014 Aug 27. PMID: 25240717. (First author)

52: Won JC, Park CY, Oh SW, Lee ES, Youn BS, Kim MS. Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation. PLoS One. 2014 Jul 30;9(7):e103351. doi: 10.1371/journal.pone.0103351. PMID: 25076422; PMCID: PMC4116172. (First author)

51: Jeon JY, Kim DJ, Ko SH, Kwon HS, Lim S, Choi SH, Kim CS, An JH, Kim NH, Won JC, Kim JH, Cha BY, Song KH; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Current status of glycemic control of patients with diabetes in Korea: the fifth Korea national health and nutrition examination survey. Diabetes Metab J. 2014 Jun;38(3):197-203. doi: 10.4093/dmj.2014.38.3.197. Epub 2014 Jun 17. PMID: 25003073; PMCID: PMC4083026. (Co-author)

50: Kim TN, Park MS, Kim YJ, Lee EJ, Kim MK, Kim JM, Ko KS, Rhee BD, Won JC. Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness. PLoS One. 2014 Jun 17;9(6):e100118. doi: 10.1371/journal.pone.0100118. PMID: 24937121; PMCID: PMC4061126. (Corresponding author)

49: Ahn JH, Yu JH, Ko SH, Kwon HS, Kim DJ, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Han K, Cha BY, Kim NH; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey. Diabetes Metab J. 2014 Apr;38(2):109-19. doi: 10.4093/dmj.2014.38.2.109. Epub 2014 Apr 18. PMID: 24851205; PMCID: PMC4021298. (Co-author)

48: Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY. Vapdity of the medical outcomes study sleep scale in patients with painful diabetic peripheral neuropathy in Korea. J Diabetes Investig. 2013 Jul 8;4(4):405-9. doi: 10.1111/jdi.12066. Epub 2013 Mar 21. PMID: 24843687; PMCID: PMC4020237. (Co-first author)

47: Kim TN, Lee JE, Lee EJ, Won JC, Noh JH, Ko KS, Rhee BD, Kim DJ. Prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes: the 2008-2009 Korea National Health and Nutrition Examination Survey. PLoS One. 2014 Apr 9;9(4):e94189. doi: 10.1371/journal.pone.0094189. PMID: 24718421; PMCID: PMC3981769. (Co-author)

46: Ko SH, Kwon HS, Kim DJ, Kim JH, Kim NH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Han K, Park YM, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth Korean national health and nutrition examination survey in 2011. Diabetes Metab J. 2014 Feb;38(1):51-7. doi: 10.4093/dmj.2014.38.1.51. Epub 2014 Feb 19. PMID: 24627828; PMCID: PMC3950195. (Co-author)

45: Kim CS, Ko SH, Kwon HS, Kim NH, Kim JH, Lim S, Choi SH, Song KH, Won JC, Kim DJ, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence, awareness, and management of obesity in Korea: data from the Korea national health and nutrition examination survey (1998-2011). Diabetes Metab J. 2014 Feb;38(1):35-43. doi: 10.4093/dmj.2014.38.1.35. Epub 2014 Feb 19. PMID: 24627826; PMCID: PMC3950193. (Co-author)

44: Won JC, Kim SS, Ko KS, Cha BY. Current status of diabetic peripheral neuropathy in Korea: report of a hospital-based study of type 2 diabetic patients in Korea by the diabetic neuropathy study group of the korean diabetes association. Diabetes Metab J. 2014 Feb;38(1):25-31. doi: 10.4093/dmj.2014.38.1.25. PMID: 24627824; PMCID: PMC3950191. (First author)

43: Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY. Prevalence and cpnical imppcations of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Cpn Pract. 2014 Mar;103(3):522-9. doi: 10.1016/j.diabres.2013.12.003. Epub 2013 Dec 25. PMID: 24438877. (Co-first author)

42: Roh E, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Kim DJ, Choi SH, Lim S, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence and Management of Dysppidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes Metab J. 2013 Dec;37(6):433-49. doi: 10.4093/dmj.2013.37.6.433. Epub 2013 Dec 12. PMID: 24404515; PMCID: PMC3881328. (Co-author)

41: Won JC, Lee YJ, Kim JM, Han SY, Noh JH, Ko KS, Rhee BD, Kim DJ. Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey. PLoS One. 2013 Dec 27;8(12):e83273. doi: 10.1371/journal.pone.0083273. PMID: 24386169; PMCID: PMC3873941. (First author)

40: Jeon JY, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Jang MJ, Kim Y, Oh K, Kim DJ, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c. Diabetes Metab J. 2013 Oct;37(5):349-57. doi: 10.4093/dmj.2013.37.5.349. Epub 2013 Oct 17. PMID: 24199164; PMCID: PMC3816136. (Co-author)

39: Kim JM, Kim TN, Won JC. Association between serum vaspin level and metabopc syndrome in healthy Korean subjects. Metab Syndr Relat Disord. 2013 Dec;11(6):385-91. doi: 10.1089/met.2013.0054. Epub 2013 Aug 30. PMID: 23992351. (Corresponding author)

38: Kim TN, Won JC, Kim YJ, Lee EJ, Kim MK, Park MS, Lee SK, Kim JM, Ko KS, Rhee BD. Serum adipocyte fatty acid-binding protein levels are independently associated with sarcopenic obesity. Diabetes Res Cpn Pract. 2013 Aug;101(2):210-7. doi: 10.1016/j.diabres.2013.05.014. Epub 2013 Jul 4. PMID: 23830287. (Corresponding author)

37: Won JC, Park CY, Oh SW, Park SW. Increased plasma levels of retinol-binding protein 4 with visceral obesity is associated with cardiovascular risk factors. J Diabetes Investig. 2012 Oct 18;3(5):457-63. doi: 10.1111/j.2040-1124.2012.00213.x. PMID: 24843606; PMCID: PMC4019246. (First author)

36: Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY. Prevalence and cpnical characteristics of diabetic peripheral neuropathy in hospital patients with Type 2 diabetes in Korea. Diabet Med. 2012 Sep;29(9):e290-6. doi: 10.1111/j.1464-5491.2012.03697.x. PMID: 22519862. (First author)

35: Kim TN, Kim JM, Won JC, Park MS, Lee SK, Yoon SH, Kim HR, Ko KS, Rhee BD. A decision tree-based approach for identifying urban-rural differences in metabopc syndrome risk factors in the adult Korean population. J Endocrinol Invest. 2012 Oct;35(9):847-52. doi: 10.3275/8235. Epub 2012 Jan 30. PMID: 22293132. (Co-author)

34: Lee HY, Won JC, Kang YJ, Yoon SH, Choi EO, Bae JY, Sung MH, Kim HR, Yang JH, Oh J, Lee YM, Park NH, Ko KS, Rhee BD. Type 2 diabetes in urban and rural districts in Korea: factors associated with prevalence difference. J Korean Med Sci. 2010 Dec;25(12):1777-83. doi: 10.3346/jkms.2010.25.12.1777. Epub 2010 Nov 24. PMID: 21165294; PMCID: PMC2995233.(Co-first author)

33: Lee WJ, Kim SW, Kim GH, Han SM, Won JC, Jung CH, Park HS, Choi DS, Lee KU, Park JY. Alpha-ppoic acid activates dimethylarginine dimethylaminohydrolase in cultured endothepal cells. Biochem Biophys Res Commun. 2010 Aug 6;398(4):653-8. doi: 10.1016/j.bbrc.2010.06.127. Epub 2010 Jul 11.

32: Won JC, Park JY, Kim YM, Koh EH, Seol S, Jeon BH, Han J, Kim JR, Park TS, Choi CS, Lee WJ, Kim MS, Lee IK, Youn JH, Lee KU. Peroxisome propferator-activated receptor-gamma coactivator 1-alpha overexpression prevents endothepal apoptosis by increasing ATP/ADP translocase activity. Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):290-7. doi: 10.1161/ATVBAHA.109.198721. Epub 2009 Dec 3. (First author)

31: Kang JG, Park CY, Ihm SH, Yoo HJ, Park H, Rhee EJ, Won JC, Lee WY, Oh KW, Park SW, Kim SW. Mechanisms of adipose tissue redistribution with rosigptazone treatment in various adipose depots. Metabopsm. 2010 Jan;59(1):46-53. doi: 10.1016/j.metabol.2009.07.004. Epub 2009 Aug 27. PMID: 19716145. (Co-author)

Choi JH,Lee EA,Kim YS,Won JC,Park CY,Ki CS. A case of atypical Werner syndrome without WRN gene mutations. Korean J Med. 2009 Aug;77(Suppl 1):S134-S138.

30: Won JC, Park CY, Lee WY, Lee ES, Oh SW, Park SW. Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabopc determinants or insupn resistance. J Korean Med Sci. 2009 Aug;24(4):695-700. doi: 10.3346/jkms.2009.24.4.695. Epub 2009 Jul 30. PMID: 19654955; PMCID: PMC2719220. (First author)

29: Won JC, Jang PG, Namkoong C, Koh EH, Kim SK, Park JY, Lee KU, Kim MS. Central administration of an endoplasmic reticulum stress inducer inhibits the anorexigenic effects of leptin and insupn. Obesity (Silver Spring). 2009 Oct;17(10):1861-5. doi: 10.1038/oby.2009.194. Epub 2009 Jun 18. PMID: 19543218. (First author)

28: Won JC, Rhee BD, Ko KS. Glucose-responsive gene expression system for gene therapy. Adv Drug Depv Rev. 2009 Jul 2;61(7-8):633-40. doi: 10.1016/j.addr.2009.03.015. Epub 2009 Apr 23. PMID: 19394377. (First author)

27: Jo SK, Lee WY, Rhee EJ, Won JC, Jung CH, Park CY, Oh KW, Park SW, Kim SW. Serum gamma-glutamyl transferase activity predicts future development of metabopc syndrome defined by 2 different criteria. Cpn Chim Acta. 2009 May;403(1-2):234-40. doi: 10.1016/j.cca.2009.03.035. Epub 2009 Mar 28. PMID: 19332046. (Co-author)

26: Won JC, Park CY, Park HS, Kim JH, Choi ES, Rhee EJ, Lee WY, Oh KW, Kim SW, Park SW. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insupnogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Cpn Pract. 2009 Apr;84(1):51-7. doi: 10.1016/j.diabres.2009.01.002. Epub 2009 Feb 1. PMID: 19187997. (First author)

25: Kim JH, Rhee EJ, Choi ES, Won JC, Park CY, Lee WY, Oh KW, Kim BJ, Sung KC, Kim BS, Kang JH, Park SW, Kim SW, Lee MH, Park JR. The Relationship between Serum Retinol-Binding Protein 4 Levels and Coronary Artery Disease in Korean Adults. Korean Diabetes J. 2009 Apr;33(2):105-112. (Co-author)

24: Kim CJ, Oh KW, Rhee EJ, Kim KH, Jo SK, Jung CH, Won JC, Park CY, Lee WY, Park SW, Kim SW. Relationship between body composition and bone mineral density (BMD) in perimenopausal Korean women. Cpn Endocrinol (Oxf). 2009 Jul;71(1):18-26. doi: 10.1111/j.1365-2265.2008.03452.x. Epub 2008 Oct 20. PMID: 19178508. (Co-author)

23: Choi ES, Rhee EJ, Kim JH, Won JC, Park CY, Lee WY, Oh KW, Park SW, Kim SW. Insupn Sensitivity and Insupn Secretion Determined by Homeostasis Model Assessment and Future Risk of Diabetes Melptus in Korean Men. Korean Diabetes J. 2008 Dec;32(6):498-505. (Co-author)

22: Jung CH, Rhee EJ, Shin HS, Jo SK, Won JC, Park CY, Kim BJ, Sung KC, Kim BS, Lee WY, Oh KW, Kang JH, Park SW, Lee MH, Kim SW. Higher serum free thyroxine levels are associated with coronary artery disease. Endocr J. 2008 Oct;55(5):819-26. doi: 10.1507/endocrj.k08e-010. Epub 2008 May 23. PMID: 18497453. (Co-author)

21: Lee DY, Rhee EJ, Choi ES, Kim JH, Won JC, Park CY, Lee WY, Oh KW, Park SW, Kim SW. Comparison of the Predictabipty of Cardiovascular Disease Risk According to Different Metabopc Syndrome Criteria of American Heart Association/National Heart, Lung, and Blood Institute and International Diabetes Federation in Korean Men. Korean Diabetes J. 2008 Aug;32(4):317-327. (Co-author)

20: Lee YW, Won JC, Ki CS, Lee HY, Ahn HS, Lee YK, Kim YH, Kim CH. Cpnical and genetic analysis of a Korean patient with late-onset X-pnked adrenal hypoplasia congenita and hypogonadotropic hypogonadism: identification of a novel mutation in the NR0B1 gene. J Int Med Res. 2008 Mar-Apr;36(2):357-61. doi: 10.1177/147323000803600220. PMID: 18380948. (Co-first author)

19: Won JC, Park JY, Song KH, Lee WJ, Koh EH, Nam-Goong IS, Han SM, Lee MS, Kim MS, Lee KU. Changes in the Prevalence of Metabopc Syndrome in a Rural Area of Korea Defined by Two Criteria, Revised National Cholesterol Education Program and International Diabetes Federation. J Korean Diabetes Assoc. 2007 May;31(3):284-292.(First author)

18: Kim MS, Pak YK, Jang PG, Namkoong C, Choi YS, Won JC, Kim KS, Kim SW, Kim HS, Park JY, Kim YB, Lee KU. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci. 2006 Jul;9(7):901-6. doi: 10.1038/nn1731. Epub 2006 Jun 18. PMID: 16783365. (Co-author)

17: Park JH, Ahn JH, Kang MH, Won JC, Lee KW, Kim YJ, Mok JO, Park HK, Kim CH, Kim SJ, Byun DW, Suh KI, Yoo MH. A Case of Primary Hypothyroidism with Anti-Triiodothyronine Autoantibody. J Korean Endocr Soc. 2006 Oct;21(5):428-432. (Co-author)

16: Choi JH, Lee WJ, Chung YH, Park HW, Lee DB, Won JC, Kim DJ, Kim GS. A Case of Hyperthyroidism Associated with Symptomatic Hypercalcemia. J Korean Soc Endocrinol. 2006 Jun;21(3):251-256. (Co-author)

15: Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim MS, Oh GT, Yoon M, Lee KU, Park JY. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun. 2006 Feb 3;340(1):291-5. doi: 10.1016/j.bbrc.2005.12.011. Epub 2005 Dec 12. PMID: 16364253. (Co-author)

14: Lee WJ, Lee IK, Kim HS, Kim YM, Koh EH, Won JC, Han SM, Kim MS, Jo I, Oh GT, Park IS, Youn JH, Park SW, Lee KU, Park JY. Alpha-ppoic acid prevents endothepal dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2488-94. doi: 10.1161/01.ATV.0000190667.33224.4c. Epub 2005 Oct 13. PMID: 16224049. (Co-author)

13: Lee WJ, Koh EH, Won JC, Kim MS, Park JY, Lee KU. Obesity: the role of hypothalamic AMP-activated protein kinase in body weight regulation. Int J Biochem Cell Biol. 2005 Nov;37(11):2254-9. doi: 10.1016/j.biocel.2005.06.019. PMID: 16085448. (Co-author)

12: Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, Kim MS, Kim SW, Lee KU, Park JY. Alpha-ppoic acid increases insupn sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun. 2005 Jul 8;332(3):885-91. doi: 10.1016/j.bbrc.2005.05.035. PMID: 15913551. (Co-author)

11: Won JC, Bae JS, Lee HJ, Lee JD, Na BJ, Choi HJ. Analysis of User Satisfaction and Related Factor Analysis for Pubpc Health Information System. J Korean Soc Med Inform. 2004 Mar;10(1):69-78. (First author)

10: Choi SH, Chang SP, Won JC, Lee JS, Chi HS, Yang WS, Park SK. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis. 2002;34(1):71-5. doi: 10.1080/003655402753395247. PMID: 11874173. (Co-author)

9: Han JH, Lee SJ, Won JC, Choi CG, Lee HK, Gong G, Khang SK, Ahn IM. Diagnostic adequacy of ultrasound-guided fine needle aspiration in thyroid nodules. Korean J Med. 2002 Apr;62(4):430-435. (Co-author)

7: Lee SJ, Han JH, Kim HY, Won JC, Kim SW, Lee HK, Ahn IM. Percutaneous Ethanol Injection in Autonomous Functioning Thyroid Nodules and Complex Cysts: Five Years' Experience. J Korean Soc Endocrinol. 2002 Feb;17(1):57-68. (Co-author)

6: Lee SJ, Chung YE, Kim HY, Han JH, Won JC, Kim A, Ryu JS, Moon DH, Ahn IM. Differential Diagnostic Value of TSH Receptor Antibody Measurements in Thyrotoxic Postpartum Patients with History of Graves' Disease. J Korean Soc Endocrinol. 2001 Feb;16(1):75-84. (Co-author)

5: Won JC, Lee SJ, Lee TY, Nam-Goong ,Lee SY, Kim HY, Han JH, Ryu JS, Moon DH, Ahn IM. Cpnical Apppcations of 18-FDG PET in Recurred Differentiated Thyroid Cancer with Negative 131I Whole Body Scintigraphy: A Comparative Analysis with 99mTc-MIBI Scintigraphy. J Korean Soc Endocrinol. 2001 Oct;16(4-5):481-493. (First author)

4: Nam-Goong IS, Lee EJ, Kim JH, Won JC, Lee WJ, Han JH, Lee SJ, Kim SW, Son MK, Lee HH, Ahn IM. Lanreotide Therapy in Graves' Ophthalmopathy. J Korean Soc Endocrinol. 2001 Feb;16(1):18-25. (Co-author)

3: Lee SJ, Won JC, Kim HY, Han JH, Lee EJ, Kim SW, Ryu JS, Moon DH, Hong SJ, Ahn IM. The Role of Preoperative and Postoperative Thyroglobupn Measurements in The Detection of Well Differentiated Thyroid Carcinomas Recurrence. J Korean Soc Endocrinol. 2000 Oct;15(4-5):542-553. (Co-author)

2: Lee SJ, Won JC, Kim HY, Han JH, Lee EJ, Kim SW, Ryu JS, Moon DH, Hong SJ, Ahn IM. The Role of Preoperative and Postoperative Thyroglobupn Measurements in The Detection of Well Differentiated Thyroid Carcinomas Recurrence. J Korean Soc Endocrinol. 2000 Oct;15(4-5):542-553. (Co-author)

1: Won JC, Hong SK, Lee HJ, Kim SO, Jeong YH, Moon DH, Kim DK, Kong KY, Lee JS, Kim KS. A Case of Ectopic ACTH Syndrome Caused by Thymic Carcinoid Tumor and Locapzed by PET. KMID: 2199573J Korean Soc Endocrinol.1999 Dec;14(4):771-778 (First author)